The MBL2 ‘LYQA Secretor’ Haplotype Is an Independent Predictor of Postoperative Myocardial Infarction in Whites Undergoing Coronary Artery Bypass Graft Surgery

Background— Mannose-binding lectin (MBL) is an important component of innate immunity and activator of the lectin complement pathway. Within theMBL2 gene are seven 5′ “secretor” haplotypes that code for altered serum MBL levels and complement activation. However, recent evidence suggests that 3′MBL2 haplotypes may also modify MBL function and circulating levels. Because MBL and the lectin complement pathway have been implicated in cardiovascular injury, we investigated whetherMBL2 haplotypes are independently associated with an increased risk of postoperative myocardial infarction (PMI) in patients undergoing coronary artery bypass graft surgery.Methods and Results— Genotyping of 18 polymorphic sites within theMBL2 gene was performed in a prospective, longitudinal multi-institutional study of 978 patients undergoing primary coronary artery bypass graft-only surgery with cardiopulmonary bypass between August 2001 and May 2005. After adjustment for multiple comparisons by permutation testing, multivariate, stepwise logistic regression, including a score test, was performed controlling for patient demographics, preoperative risk factors, medications, and intraoperative variables to determine ifMBL2 secretor haplotypes are independent predictors of PMI in whites undergoing primary coronary artery bypass graft surgery. Neither the 5′ nor 3′MBL2 haplotypes alone were associated with an increased incidence of PMI. However, the incidence of PMI in whites (n=843) expressing the combinedMBL2 5′ LYQA secretor haplotype (CGTCGG) and 3′ haplotype (CGGGT) was significantly higher than in whites not expressing the haplotype (38% versus 10%;P <0.007). Moreover, the combinedMBL2 LYQA secretor haplotype was an independent predictor of PMI in whites after primary coronary artery bypass graft surgery after adjustment for other covariates (P <0.02; adjusted OR: 3.97; 95% CI: 1.30 to 12.07). The combinedMBL2 LYQA secretor haplotype in whites was also an independent predictor of postoperative CKMB levels exceeding 60 ng/mL (P <0.02; adjusted OR: 4.48; 95% CI: 1.95 to 16.80). Inclusion of the combinedMBL2 LYQA secretor haplotype improved prediction models for PMI based on traditional risk factors alone (C-statistic 0.715 versus 0.705).Conclusions— The combinedMBL2 LYQA secretor haplotype is a novel independent predictor of PMI and may aid in preoperative risk stratification of whites undergoing primary coronary artery bypass graft surgery.